Why the study?
Significant sex-related disparities persist in the pharmacologic treatment of women with acute coronary syndrome, leading to suboptimal treatment and poorer outcomes.
Are there sex-specific differences in the medical management of acute coronary syndrome between women and men?
Are there sex-specific differences in the medical management of acute coronary syndrome between women and men?
Answers are grounded in this paper and cite their sources.
Despite guidelines recommending identical treatment for men and women with ACS, women consistently receive less intensive pharmacotherapy and experience worse outcomes, highlighting a critical gap in care.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
J. et al. (2025) conducted a review in Acute Coronary Syndrome. Guideline-recommended pharmacotherapy vs. Men was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: